Skip to main content
main-content

01.06.2015 | Original Article | Ausgabe 6/2015

Supportive Care in Cancer 6/2015

Substantial decreases in the number and diversity of microbiota during chemotherapy-induced gastrointestinal mucositis in a rat model

Zeitschrift:
Supportive Care in Cancer > Ausgabe 6/2015
Autoren:
Margot Fijlstra, Mithila Ferdous, Anne M. Koning, Edmond H. H. M. Rings, Hermie J. M. Harmsen, Wim J. E. Tissing
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1007/​s00520-014-2487-6) contains supplementary material, which is available to authorized users.

Relevance of our manuscript to inform research, policies, and/or programs

In this manuscript, we demonstrate that rats with gastrointestinal mucositis show substantial decreases in the number and diversity of microbiota, thereby favoring potentially enteropathogenic bacteria. Our findings resemble earlier findings in mucositis patients. The model therefore seems well suited to study the microbiota in relation to mucositis and to study if microbial interventions (like the use of prebiotics, probiotics, and antibiotics) can change the course of mucositis, prior to performing selected studies in vulnerable mucositis patients. Our work is relevant for everyone who is involved in the caretaking of patients with mucositis (doctors, dieticians, other caretakers) but especially for producers of agents aiming at restoring dysbioisis and/or enhancing recovery from mucositis (food industries, pharmacologists, researchers, etc.): The effects of their products on mucositis might well be studied in the mucositis model.

Abstract

Purpose

Earlier, we showed in acute myeloid leukemia (AML) patients that the microbiota changes dramatically during anticancer treatment, coinciding with gastrointestinal mucositis: The commensal anaerobic populations reduce in favor of potential pathogens. Therefore, interventions targeting the microbiota during mucositis might be interesting but can better be tested in animals than in vulnerable mucositis patients. Here, we aimed to study the potential microbial changes during methotrexate (MTX)-induced gastrointestinal mucositis in a well-established rat model and to study whether this model can be used for future microbial intervention studies.

Methods

After injection with MTX or saline (day 0), rats were sacrificed between days 2 and 11. Plasma citrulline level, jejunal histology, and the number and diversity of intestinal bacteria in feces (using fluorescence in situ hybridization (FISH)) were determined.

Results

Mucositis was most severe on day 4 when food intake, plasma citrulline, and villus length were the lowest, compared with controls (P < 0.0125). At the same time, MTX-treated rats showed an overall decrease (705-fold) in most bacteria (using a universal probe), compared with controls (P < 0.125). Reduced bacterial presence was related with the presence of diarrhea and a reduced villus length (rho = 0.38, P < 0.05). At day 4, there was an absolute and relative decrease of anaerobes (13-fold and −58 %, respectively) and streptococci (296-fold and −1 %, respectively) but a relative increase of Bacteroides (+49 %), compared with controls (P < 0.125).

Conclusions

In the mucositis rat model, we found substantial decreases in the number and diversity of microbiota, resembling earlier findings in humans. The model therefore seems well suited to study the effects of different microbial interventions on mucositis, prior to performing human studies.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de. Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Weitere Produktempfehlungen anzeigen
Zusatzmaterial
Online Resource 1 Clinical and histological findings in the mucositis rat model. Food intake (A), body weight (relative to weight at day 0, B), plasma citrulline concentration (C) and jejunal crypt and villus length (D and E respectively) in saline-treated rats (controls, ○ ---, n = 12) and methotrexate-treated rats (MTX, ● ▬, n = 21), up to 10 days after i.v. saline- or MTX-injection (day 0, see ‘ Materials and methods’). Intake is shown until day 9, since rats were terminated at day 10 or 11. Data represent medians and first to third quartiles (p 25-p 75, A-B) or medians and data for individual rats (C-E). # P < 0.05 for controls versus MTX-treated rats, * P < 0.0125 for controls versus MTX-treated rats. (PDF 58 kb)
Online Resource 2 Correlation between the absolute number of most bacteria and villus length in the mucositis rat model. Data correspond with data from Online Resource 1E (villus length) and Fig.  1a (most bacteria, using a universal probe), in saline-treated rats (controls, ○, n = 12), methotrexate-treated rats with diarrhea (MTX, ■, n = 5) and methotrexate-treated rats without diarrhea (MTX, ● , n = 16). The Spearman-correlation (r) and P-value is indicated. (PDF 36 kb)
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 6/2015

Supportive Care in Cancer 6/2015 Zur Ausgabe
  1. Das kostenlose Testabonnement läuft nach 14 Tagen automatisch und formlos aus. Dieses Abonnement kann nur einmal getestet werden.

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise